Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Terriou

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|September 16, 2014
Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimenE Gomez, R Duléry, C Langlois, et al.
Annales De Dermatologie Et De Venereologie|May 7, 2008
[Intravascular lymphoma revealed by generalized arborescent telangiectasia and repeated venous thrombosis]S Vercambre-Darras, L Mortier, M Lambert, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 15, 2015
Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to RituximabJ Rossignol, L Terriou, D Robu, et al.
Leukemia|June 27, 2012
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphomaH Tilly, F Morschhauser, G Salles, et al.
La Revue De Medecine Interne|February 16, 2005
[Thalidomide: mechanisms of action and new insights in hematology]X Leleu, J B Micol, R Guieze, et al.
La Revue De Medecine Interne|September 29, 2015
[Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome]M Jouvray, L Terriou, V Meignin, et al.
Leukemia & Lymphoma|February 28, 2007
Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature reviewJ B Micol, C Berthon, S Tricot, et al.
Leukemia|September 23, 2006
High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosisA Renneville, B Quesnel, A Charpentier, et al.
Leukemia|May 26, 2012
Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimensS Manier, M Barthelemy, G Fouquet, et al.
Leukemia|September 14, 2007
Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AMLV Biggio, A Renneville, O Nibourel, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|September 16, 2014
Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimenE Gomez, R Duléry, C Langlois, et al.
Annales De Dermatologie Et De Venereologie|May 7, 2008
[Intravascular lymphoma revealed by generalized arborescent telangiectasia and repeated venous thrombosis]S Vercambre-Darras, L Mortier, M Lambert, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 15, 2015
Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to RituximabJ Rossignol, L Terriou, D Robu, et al.
Leukemia|June 27, 2012
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphomaH Tilly, F Morschhauser, G Salles, et al.
La Revue De Medecine Interne|February 16, 2005
[Thalidomide: mechanisms of action and new insights in hematology]X Leleu, J B Micol, R Guieze, et al.
La Revue De Medecine Interne|September 29, 2015
[Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome]M Jouvray, L Terriou, V Meignin, et al.
Leukemia & Lymphoma|February 28, 2007
Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature reviewJ B Micol, C Berthon, S Tricot, et al.
Leukemia|September 23, 2006
High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosisA Renneville, B Quesnel, A Charpentier, et al.
Leukemia|May 26, 2012
Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimensS Manier, M Barthelemy, G Fouquet, et al.
Leukemia|September 14, 2007
Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AMLV Biggio, A Renneville, O Nibourel, et al.
Pageof 3